Latest KFF Health News Content

Latest KFF Health News Stories

Administration Urged To Use Workaround To Slash Cost Of Pricey Anti-Overdose Drug

Morning Briefing

Baltimore’s health department and a national advocacy group wrote to the Trump administration asking officials to take action. Meanwhile, Mayor Bill de Blasio wants to make New York City a pioneer in creating supervised safe injection sites.

Congressional Oversight Lags Far Behind Fast-Growing Commercial DNA Testing

Morning Briefing

Despite consumer unease about their DNA privacy, especially on the heels of the Golden State Killer case, Congress has made no moves to update the 2008 Genetic Information Nondiscrimination Act, the lone law in this field.

Health Insurers On ‘Hot Streak’ Despite Worries Over Nasty Flu Season

Morning Briefing

One big reason for the Q1 windfall is the tax cuts passed by Congress last year, which in some cases more than halved what the insurers owe the government. Meanwhile, conservative groups are drawing up a new “repeal” plan, but Republicans aren’t sold.

‘Pharma Bro’ Shkreli Is In Prison, But Daraprim’s Price Is Still High

KFF Health News Original

The saga of Martin Shkreli and Turing Pharmaceuticals focused a lot of attention on prescription drug prices, but no reversal of the exponential price increases for the lifesaving drug Daraprim resulted. The story offers an object lesson into the interworkings of the pharmaceutical market.

Weak Oversight Blamed For Poor Care At California Nursing Homes Going Unchecked

KFF Health News Original

The scathing report cites a significant increase in cases of poor care — especially ones with the potential to cause serious injuries or death. A state lawmaker called the findings “very, very disturbing.”

Podcast: KHN’s ‘What The Health?’ Medicaid, Privacy And Tom Price’s Return

KFF Health News Original

Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Talking Points Memo discuss the latest on states’ efforts to reshape their Medicaid programs, the kerfuffle over President Donald Trump’s medical records and comments by former Health and Human Services Secretary Tom Price about Congress’ repeal of the Affordable Care Act’s “individual mandate” penalty. Rovner also interviews Harvard professor Robert Blendon about the complex politics of health in the coming midterm elections.

Scientists Identify Autism Signpost That Could Eventually Lead To Treatment For The Disorder

Morning Briefing

Researchers found a correlation between a hormone and autism-like behavior in monkeys, which could be used to diagnose the disorder. The hormone could also become a drug target if future studies show boosting its levels can assuage social impairments. In other public health news: cancer screenings, gene-editing, tick-borne diseases, empathy, strokes, and more.